SEHK:2171Biotechs
CARsgen Therapeutics Holdings (SEHK:2171): Valuation Check After Zevor‑cel Listing and New CT0596 Data
CARsgen Therapeutics Holdings (SEHK:2171) just checked two important boxes for investors, with zevor cel entering China’s new Innovative Drug Catalogue and fresh CT0596 data showcased at the ASH congress.
See our latest analysis for CARsgen Therapeutics Holdings.
Even with the share price sitting at HK$15.0 after a steep 90 day share price return of minus 28.77 percent and a softer 30 day share price return of minus 13.34 percent, the strong year to date share price return of 59.91 percent...